BioNotebook: OncoMed CEO Hastings at BIO 2014; Biotech jobs numbers; Morphotek, Sorrento deal; offerings and IPOs | PharmaBoardroom
written on 30.06.2014
Tags:
,

BioNotebook: OncoMed CEO Hastings at BIO 2014; Biotech jobs numbers; Morphotek, Sorrento deal; offerings and IPOs

TAGS: ,

OncoMed CEO discusses partial hold; BIO, Biocom/BayBio report jobs numbers; Morphotek, Sorrento partner on ADCs; Prothena, Heron, OncoGenex price offerings; and IPO updates from Amphastar, Microlin, Syndax, Revo, Zosano, Tobira.

Latest Report